Edition:
United Kingdom

Regenxbio Inc (RGNX.OQ)

RGNX.OQ on NASDAQ Stock Exchange Global Select Market

64.90USD
7:49pm BST
Change (% chg)

$-0.35 (-0.54%)
Prev Close
$65.25
Open
$65.45
Day's High
$65.45
Day's Low
$63.85
Volume
76,197
Avg. Vol
208,520
52-wk High
$85.05
52-wk Low
$19.50

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 40.03 0.300
Mar '18 132.39 3.041
FY 2017 Dec '17 2.04 -0.513
Sep '17 1.34 -0.669
Jun '17 6.56 -0.472
Mar '17 0.46 -0.825
FY 2016 Dec '16 1.70 -0.741
Sep '16 0.12 -0.686
Jun '16 2.38 -0.548
Mar '16 0.39 -0.409
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 1 0.00 0.00 0.00 --
Quarter Ending Dec-18 1 0.00 0.00 0.00 --
Year Ending Dec-18 5 198.98 232.39 176.00 5.35
Year Ending Dec-19 4 8.20 13.70 2.10 4.74
Earnings (per share)
Quarter Ending Sep-18 2 -0.89 -0.88 -0.91 --
Quarter Ending Dec-18 2 -0.92 -0.92 -0.92 --
Year Ending Dec-18 4 2.73 3.70 1.80 -3.30
Year Ending Dec-19 5 -4.07 -2.97 -5.07 -3.66
LT Growth Rate (%) 1 4.00 4.00 4.00 -28.50
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.68 32.76
P/E High - Last 5 Yrs. -- 300.64 45.44
P/E Low - Last 5 Yrs. -- 92.08 24.26
Beta -- 0.93 0.89
Price to Sales (TTM) 117.63 114.98 5.75
Price to Book (MRQ) 4.90 15.51 5.47
Price to Tangible Book (MRQ) 4.91 14.52 7.04
Price to Cash Flow (TTM) -- 72.88 23.29
% Owned Institutions 74.23 14.70 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.36 1.51
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.72 5.22
Payout Ratio(TTM) -- 16.50 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 176.29 411.54 8.01
Sales (TTM) vs TTM 1 Yr. Ago 5.77 80.50 5.64
Sales - 5 Yr. Growth Rate -- 32.27 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago 13.81 29.15 20.60
EPS (TTM) vs TTM 1 Yr. Ago -90.63 -- --
EPS - 5 Yr. Growth Rate -- 39.84 10.66
Capital Spending - 5 Yr. Growth Rate -- 40.43 15.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.91 2.22
Current Ratio (MRQ) 14.47 5.53 3.03
LT Debt to Equity (MRQ) 0.00 35.26 12.51
Total Debt to Equity (MRQ) 0.00 37.08 16.85
Interest Coverage (TTM) -- -102.44 32.63

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 79.94 39.17 54.37
Gross Margin - 5 Yr. Avg. -- 50.57 52.17
EBITD Margin (TTM) -852.14 -- --
EBITD - 5 Yr. Avg -- -603.21 10.65
Operating Margin (TTM) -872.54 -759.76 4.32
Operating Margin - 5 Yr. Avg. -- -625.13 6.06
Pre-Tax Margin (TTM) -844.80 -733.60 5.18
Pre-Tax Margin - 5 Yr. Avg. -- -628.46 6.49
Net Profit Margin (TTM) -839.87 -734.98 1.48
Net Profit Margin - 5 Yr. Avg. -- -631.51 2.77
Effective Tax Rate (TTM) -- 23.33 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.66 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) 82,598 23,229,989 860,364,431
Net Income/Employee (TTM) -693,720 3,144,143 101,205,929
Receivable Turnover (TTM) 21.22 20.89 5.87
Inventory Turnover (TTM) -- 2.46 3.41
Asset Turnover (TTM) 0.04 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -34.49 -0.16 11.13
Return on Assets - 5 Yr. Avg. -- 3.50 12.40
Return on Investment (TTM) -36.22 1.78 14.61
Return on Investment - 5 Yr. Avg. -- 2.55 16.13
Return on Equity (TTM) -36.40 3.28 16.33
Return on Equity - 5 Yr. Avg. -- 3.42 17.39
  1 Year 3 Year 5 Year
Sales % -39.52 -8.99 --
EPS (TTM) % -146.13 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Regenxbio Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 30.93 26.42 90 53
13 Week 66.17 58.08 92 66
26 Week 98.53 83.43 92 80
52 Week 119.08 85.68 90 50
YTD 81.40 59.31 82 61
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 82.58%
# of Holders: 258
Total Shares Held: 26,680,168
3 Mo. Net Change: 3,730,338
# New Positions: 98
# Closed Positions: 21
# Increased Positions: 174
# Reduced Positions: 67
# Net Buyers: 107
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.